Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

Vaccines Market Growth, Share Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

With the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to creating ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

The Inactivated Vaccines Market was valued at US$ 40.6 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 ...

The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

Novavax, Inc. today announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, RPh, has been appointed as his successor. The Company also appointed John Shiver, PhD, to ...